Revisiting CB1 receptor as drug target in human melanoma
- PMID: 22447182
- DOI: 10.1007/s12253-012-9515-y
Revisiting CB1 receptor as drug target in human melanoma
Abstract
Previous studies have indicated the antitumoral effect of human melanocytes, human melanoma cell lines expressing CB1 receptor (CB1), and of the peritumoral administration of endocannabinoids. In the present study, we systematically screened several human melanoma cell lines for the expression of CNR1 and demonstrated transcription of the authentic gene. The product of CNR1, the CB1 protein, was found localized to the cell membrane as well as to the cytoskeleton. Further, the studied human melanoma cell lines expressed functional CB1 since physiological and synthetic ligands, anandamide (AEA), Met-F-AEA, ACEA and AM251 showed a wide range of biological effects in vitro, for example anti-proliferative, proapoptotic and anti-migratory. More importantly, our studies revealed that systemic administration of a stable CB1 agonist, ACEA, into SCID mice specifically inhibited liver colonization of human melanoma cells. Since therapeutic options for melanoma patients are still very limited, the endocannabinoid-CB1 receptor system may offer a novel target.
Similar articles
-
FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway.Oncotarget. 2014 May 15;5(9):2475-86. doi: 10.18632/oncotarget.1723. Oncotarget. 2014. PMID: 24811863 Free PMC article.
-
CB1 cannabinoid receptor-mediated anandamide signaling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy.Neuroscience. 2016 Nov 19;337:17-26. doi: 10.1016/j.neuroscience.2016.08.047. Epub 2016 Sep 3. Neuroscience. 2016. PMID: 27595886
-
[Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts].Zhonghua Zhong Liu Za Zhi. 2011 Apr;33(4):256-9. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21575494 Chinese.
-
Cannabinoids and their derivatives in struggle against melanoma.Pharmacol Rep. 2021 Dec;73(6):1485-1496. doi: 10.1007/s43440-021-00308-1. Epub 2021 Jul 15. Pharmacol Rep. 2021. PMID: 34264513 Free PMC article. Review.
-
Rationalizing a prospective coupling effect of cannabinoids with the current pharmacotherapy for melanoma treatment.WIREs Mech Dis. 2024 Jan-Feb;16(1):e1633. doi: 10.1002/wsbm.1633. Epub 2023 Nov 3. WIREs Mech Dis. 2024. PMID: 37920964 Review.
Cited by
-
Aquaporin-1 Protein Expression of the Primary Tumor May Predict Cerebral Progression of Cutaneous Melanoma.Pathol Oncol Res. 2020 Jan;26(1):405-410. doi: 10.1007/s12253-018-0513-6. Epub 2018 Oct 30. Pathol Oncol Res. 2020. PMID: 30378011
-
Cannabinoids in the Pathophysiology of Skin Inflammation.Molecules. 2020 Feb 4;25(3):652. doi: 10.3390/molecules25030652. Molecules. 2020. PMID: 32033005 Free PMC article. Review.
-
AM1172 (a hydrolysis-resistant endocannabinoid analog that inhibits anandamide cellular uptake) reduces the viability of the various melanoma cells, but it exerts significant cytotoxic effects on healthy cells: an in vitro study based on isobolographic analysis.Pharmacol Rep. 2024 Feb;76(1):154-170. doi: 10.1007/s43440-023-00557-2. Epub 2023 Nov 29. Pharmacol Rep. 2024. PMID: 38019413 Free PMC article.
-
Comparative expression study of the endo-G protein coupled receptor (GPCR) repertoire in human glioblastoma cancer stem-like cells, U87-MG cells and non malignant cells of neural origin unveils new potential therapeutic targets.PLoS One. 2014 Mar 24;9(3):e91519. doi: 10.1371/journal.pone.0091519. eCollection 2014. PLoS One. 2014. PMID: 24662753 Free PMC article.
-
Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches.Cells. 2021 Dec 2;10(12):3396. doi: 10.3390/cells10123396. Cells. 2021. PMID: 34943903 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous